# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-21-027241
Filing Date
2021-05-13
Accepted
2021-05-13 08:25:43
Documents
49
Period of Report
2021-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | hrtx-8k_20210513.htm iXBRL | 8-K | 36182
2 | EX-99.1 | hrtx-ex991_7.htm | EX-99.1 | 27930
3 | EX-99.1 | hrtx-ex991_152.htm | EX-99.1 | 35170
4 | GRAPHIC | slide-0ctmiy2jk5e.jpg | GRAPHIC | 287700
5 | GRAPHIC | slide-n4hkrfx5bay.jpg | GRAPHIC | 288853
6 | GRAPHIC | slide-3jqnny1uhep.jpg | GRAPHIC | 141195
7 | GRAPHIC | slide-k0ro4r1ksuj.jpg | GRAPHIC | 190985
8 | GRAPHIC | slide-zrfaosafqs3.jpg | GRAPHIC | 302226
9 | GRAPHIC | slide-5dhjsuvec3p.jpg | GRAPHIC | 254842
10 | GRAPHIC | slide-c5kx3njplj3.jpg | GRAPHIC | 244174
11 | GRAPHIC | slide-1uotb2i43ql.jpg | GRAPHIC | 230928
12 | GRAPHIC | slide-krdy23ascql.jpg | GRAPHIC | 265084
13 | GRAPHIC | slide-xj4nb5vthkq.jpg | GRAPHIC | 239679
14 | GRAPHIC | slide-s3fhvdttnnr.jpg | GRAPHIC | 227537
15 | GRAPHIC | slide-mb5lrfgk5xc.jpg | GRAPHIC | 221474
16 | GRAPHIC | slide-nml3d221mid.jpg | GRAPHIC | 265464
17 | GRAPHIC | slide-enm0fwddgwi.jpg | GRAPHIC | 183907
18 | GRAPHIC | slide-edroxtwyejb.jpg | GRAPHIC | 292323
19 | GRAPHIC | slide-oobmhop2msj.jpg | GRAPHIC | 303162
20 | GRAPHIC | slide-4jrr3pq5pzf.jpg | GRAPHIC | 270528
21 | GRAPHIC | slide-xya5jfewwq3.jpg | GRAPHIC | 137987
22 | GRAPHIC | slide-tq50dolvfj4.jpg | GRAPHIC | 212097
23 | GRAPHIC | slide-drvxcrvzv4w.jpg | GRAPHIC | 152945
24 | GRAPHIC | slide-fd0itmrixzx.jpg | GRAPHIC | 173507
25 | GRAPHIC | slide-kgnq44faotv.jpg | GRAPHIC | 198970
26 | GRAPHIC | slide-arywqbbv5k0.jpg | GRAPHIC | 325586
27 | GRAPHIC | gh0j43bgtosq000001.jpg | GRAPHIC | 2932
28 | GRAPHIC | slide-4h3so5dibzg.jpg | GRAPHIC | 246164
29 | GRAPHIC | slide-jfd1s3hrvnf.jpg | GRAPHIC | 281839
30 | GRAPHIC | slide-mjojyvsf40k.jpg | GRAPHIC | 258227
31 | GRAPHIC | slide-dkme2lig0z5.jpg | GRAPHIC | 294596
32 | GRAPHIC | slide-abb43cwefoj.jpg | GRAPHIC | 288004
33 | GRAPHIC | slide-rdoihraizhs.jpg | GRAPHIC | 183446
34 | GRAPHIC | slide-mx3s5kbky0m.jpg | GRAPHIC | 155493
35 | GRAPHIC | slide-lmjxxp0vjch.jpg | GRAPHIC | 194163
36 | GRAPHIC | slide-2lotzcqghvn.jpg | GRAPHIC | 202338
37 | GRAPHIC | slide-m1uwkukuip2.jpg | GRAPHIC | 241357
38 | GRAPHIC | slide-p3uolhlxaiz.jpg | GRAPHIC | 159207
| Complete submission text file | 0001564590-21-027241.txt |  | 11162698

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
39 | XBRL TAXONOMY EXTENSION SCHEMA | hrtx-20210513.xsd | EX-101.SCH | 5772
40 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | hrtx-20210513_lab.xml | EX-101.LAB | 19482
41 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | hrtx-20210513_pre.xml | EX-101.PRE | 11631
42 | EXTRACTED XBRL INSTANCE DOCUMENT | hrtx-8k_20210513_htm.xml | XML | 3563

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 21917331
SIC: 2834 Pharmaceutical Preparations